Trials / Conditions / Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)
4 registered clinical trials studyying Carcinoma, Non-Small-Cell Lung Cancer (NSCLC) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Sta NCT07408635 | Shanghai Pulmonary Hospital, Shanghai, China | Phase 2 |
| Recruiting | An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer NCT06693336 | ToLymph Inc. | Phase 2 |
| Active Not Recruiting | Next Generation Sequencing Method for the Detection of EGFR Gene Mutations in the Plasma of Patients With Lung NCT06595498 | Istituto Oncologico Veneto IRCCS | N/A |
| Completed | A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NCT02392507 | Eli Lilly and Company | Phase 2 |